Christopher Missling

Company: Anavex Life Sciences
Job title: President & Chief Executive Officer
Seminars:
Characterizing Rare Disease Biology in Clinical Studies to Observe Drug Effects in Patient Sub-Populations 11:00 am
Understanding the relevance of Whole Exome Sequencing (WES) and mRNA-seq analyses Using unsupervised computerized AI analysis to assess large data Correlating genomic analysis with extensive clinical data outcomes and endpoint scalesRead more
day: Day One